Please login to the form below

Not currently logged in
Email:
Password:

MSD's Deepak Khanna begins his ABPI presidency

Takes over from GSK's Simon Jose

ABPI Merck Sharp Dohme MSD Deepak KhannaMerck Sharp & Dohme (MSD) UK's managing director Deepak Khanna has begun his presidency of the Association of the British Pharmaceutical Industry (ABPI).

He takes over at the UK pharma industry body from GlaxoSmithKline UK's Simon Jose, and will hold the position for one year with the option of standing for re-election in a year's time.

During his inaugural speech at the ABPI annual conference on Thursday April 26, Khanna thanked his predecessor and discussed some of the challenges facing the industry.

“In my time as president, I want to ensure that people understand the importance of our industry in developing innovative medicines and the impact these medicines can have on improving patient health and transforming people's lives. 

“I will also be focused on ensuring that we continue a constructive conversation with  government about the next pricing scheme - one which provides a fair price for medicines, encourages and supports the advancement of science through pharmaceutical R&D in the UK and also ensures that patients benefit from faster uptake of these innovative medicines.''

Commenting on Deepak's appointment, Stephen Whitehead, CEO of the ABPI, said: “I am looking forward to working with Deepak to take not only the ABPI forward, but industry as a whole.

“I want to thank Simon Jose personally for his time as president – he was a powerful advocate for the pharmaceutical industry and he leaves behind a great legacy.

“We are entering a new era of working in partnership with the NHS and Deepak's leadership in these early stages will be crucial as we imbed new ways of working that will further patient care in the UK.

“The pricing of medicines and the negotiations we are entering in to later this year will be crucial to the future success of our industry and I know that Deepak' wealth of experience will be invaluable.”

1st May 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics